NIHR and Diabetes UK invest nearly £3m to prevent and treat diabetes distress
Almost 50% of adults living with type 1 diabetes experience high levels of diabetes distress
Read More
Tag: National Institute for Health and Care Research
Study reveals cardiovascular health could be biggest risk factor for dementia
Dementias, including Alzheimer’s disease, are estimated to affect 944,000 people in the UK
Read More
NIHR awards HealthTech Research Centre Network £5m to advance health innovations
The network will support the development, evaluation and adoption of innovative health and care technology
Read More
NIHR and TJBCM announce new funding initiative for novel brain tumour research
The condition is the ninth most common cancer in the UK and affects 12,300 people annually
Read More
New UK report highlights inequalities among people living with breast cancer
Breast cancer was responsible for 2.3 million diagnoses and 670,000 deaths globally in 2022
Read More
Researchers identify group of biological markers found in high levels in TB patients
According to the World Health Organization, TB is responsible for over one million annual deaths
Read More
NIHR reveals phase 1/2 trial to evaluate an investigational vaccine for mpox in the UK
More than 3,700 cases of mpox have been identified in the UK since May 2022
Read More
New brain cancer proton beam therapy clinical trial launched in UK
The trial is recruiting patients in Leeds, Manchester, Oxford, London, Cambridge and Kent
Read More
Wearable technology to be offered to thousands with type 1 diabetes in UK
The condition affects around 270,935 people in England and 16,090 people in Wales
Read More
Babies born early have an increased risk of developmental disorders
Around 240 million children worldwide are living with these types of disorders
Read More
NIHR invests £55m to tackle health inequalities and outcomes
Millions of people in the UK are set to benefit from the second wave of funding
Read More
New NIHR Research Delivery Network in England announced by DHSC
The University of Leeds and NHS organisations will host the network in 2024
Read More
- Storm Therapeutics and AlidaBio launch collaboration to advance RNA‑targeting cancer therapies
- Excellence adventure
- MHRA approves Nucala for eosinophilic COPD in adults on triple therapy
- Bial launches new sublingual Parkinson’s treatment in UK
- Acesion Pharma launches phase 2 trial of AP31969 in atrial fibrillation
